Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance

EA Perez - Molecular cancer therapeutics, 2009 - AACR
Microtubules are important cellular targets for anticancer therapy because of their key role in
mitosis. Microtubule inhibitors (MTI) such as taxanes, vinca alkaloids, and epothilones …

New tubulin targeting agents currently in clinical development

RO Carlson - Expert opinion on investigational drugs, 2008 - Taylor & Francis
Background: The first tubulin targeting agents were approved as cancer chemotherapeutics
over 40 years ago and tubulin as an antitumor target continues to attract significant drug …

Ultrasound-assisted extraction of the three terpenoid indole alkaloids vindoline, catharanthine and vinblastine from Catharanthus roseus using ionic liquid aqueous …

L Yang, H Wang, Y Zu, C Zhao, L Zhang, X Chen… - Chemical Engineering …, 2011 - Elsevier
Ionic liquid based, ultrasound-assisted extraction (ILUAE) was successfully applied to the
extraction of 3 alkaloids, vindoline, catharanthine and vinblastine, from Catharanthus …

Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms

G Goeckenjan, H Sitter, M Thomas, D Branscheid… - …, 2010 - thieme-connect.com
Qualitätsindikatoren wurden durch Sens et al. wie folgt definiert:„Ein Indikator ist ein
quantitatives Maß, welches zum Monitoring und zur Bewertung der Qualität wichtiger …

[HTML][HTML] Second-line treatment of advanced non-small cell lung cancer

C Gridelli, A Ardizzoni, F Ciardiello, N Hanna… - Journal of Thoracic …, 2008 - Elsevier
After failure of first-line chemotherapy for advanced non-small cell lung cancer, many
patients remain candidates to receive further antitumor treatment. To guide clinical …

[HTML][HTML] A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small …

MH Cullen, P Zatloukal, S Sörenson, S Novello… - Annals of oncology, 2008 - Elsevier
Background This phase III randomized trial compared pemetrexed 500 mg/m 2 (P500) with
pemetrexed 900 mg/m 2 (P900) to determine whether higher dosing benefits non-small-cell …

Synthesis and study of a molecularly imprinted polymer for the specific extraction of indole alkaloids from Catharanthus roseus extracts

C Lopez, B Claude, P Morin, JP Max, R Pena… - Analytica chimica …, 2011 - Elsevier
Two molecularly imprinted polymers (MIP) for catharanthine and vindoline have been
synthesized in order to specifically extract these natural indole alkaloids from Catharanthus …

[PDF][PDF] 晚期非小细胞肺癌的二线治疗进展

张力 - 2008 - scholar.archive.org
疗. 目前推荐的二线治疗药物主要是多西紫杉醇, 培美曲赛和EGFR-TKIs. 多西紫杉醇最先确立其
二线治疗的地位. 培美曲赛通过一项与多西紫杉醇进行随机对照的III 期研究批准用于晚期 …

Second-line treatments in non-small cell lung cancer: a systematic review of literature and metaanalysis of randomized clinical trials

D Tassinari, E Scarpi, S Sartori, E Tamburini… - Chest, 2009 - Elsevier
Background To assess the efficacy of second-line treatments in non-small cell lung cancer.
Methods A systematic review of literature with metaanalysis of randomized clinical trials was …

How far do you go? Efficient searching for indirect evidence

N Hawkins, DA Scott, B Woods - Medical decision making, 2009 - journals.sagepub.com
Background. Indirect evidence is particularly valuable in health care decision making when
direct trial evidence comparing relevant treatments is absent or limited. Current approaches …